Raptiva rounds hot corner, heads for hotter market

October 1, 2003

Austin, Texas - Genentech's Raptiva took a significant step toward approval by the U.S. Food and Drug Administration. The psoriasis treatment received a unanimous recommendation from an FDA advisory panel.